238 related articles for article (PubMed ID: 19771320)
1. GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?
Li P; Lin JE; Marszlowicz GP; Valentino MA; Chang C; Schulz S; Pitari GM; Waldman SA
Drug News Perspect; 2009; 22(6):313-8. PubMed ID: 19771320
[TBL] [Abstract][Full Text] [Related]
2. Can colorectal cancer be prevented or treated by oral hormone replacement therapy?
Li P; Lin JE; Schulz S; Pitari GM; Waldman SA
Curr Mol Pharmacol; 2009 Nov; 2(3):285-92. PubMed ID: 20021465
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.
Li P; Lin JE; Snook AE; Gibbons AV; Zuzga DS; Schulz S; Pitari GM; Waldman SA
Clin Transl Sci; 2008 Sep; 1(2):163-7. PubMed ID: 19727435
[TBL] [Abstract][Full Text] [Related]
4. Sex modulates intestinal transformation by the tumor-suppressor GCC.
Li P; Schulz S; Pitari GM; Waldman SA
Clin Transl Sci; 2008 Sep; 1(2):146-50. PubMed ID: 20443837
[TBL] [Abstract][Full Text] [Related]
5. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.
Li P; Waldman SA
Cancer Biol Ther; 2010 Aug; 10(3):211-8. PubMed ID: 20592492
[TBL] [Abstract][Full Text] [Related]
6. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Wilson C; Lin JE; Li P; Snook AE; Gong J; Sato T; Liu C; Girondo MA; Rui H; Hyslop T; Waldman SA
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2328-37. PubMed ID: 25304930
[TBL] [Abstract][Full Text] [Related]
7. Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target.
Lin JE; Li P; Pitari GM; Schulz S; Waldman SA
Future Oncol; 2009 May; 5(4):509-22. PubMed ID: 19450179
[TBL] [Abstract][Full Text] [Related]
8. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA
Cancer Res; 2016 Jan; 76(2):339-46. PubMed ID: 26773096
[TBL] [Abstract][Full Text] [Related]
9. Guanylyl cyclase C signaling axis and colon cancer prevention.
Pattison AM; Merlino DJ; Blomain ES; Waldman SA
World J Gastroenterol; 2016 Sep; 22(36):8070-7. PubMed ID: 27688649
[TBL] [Abstract][Full Text] [Related]
10. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Valentino MA; Lin JE; Snook AE; Li P; Kim GW; Marszalowicz G; Magee MS; Hyslop T; Schulz S; Waldman SA
J Clin Invest; 2011 Sep; 121(9):3578-88. PubMed ID: 21865642
[TBL] [Abstract][Full Text] [Related]
11. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Lin JE; Li P; Snook AE; Schulz S; Dasgupta A; Hyslop TM; Gibbons AV; Marszlowicz G; Pitari GM; Waldman SA
Gastroenterology; 2010 Jan; 138(1):241-54. PubMed ID: 19737566
[TBL] [Abstract][Full Text] [Related]
12. Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology.
Uranga JA; Castro M; Abalo R
Curr Med Chem; 2018; 25(16):1879-1908. PubMed ID: 29210639
[TBL] [Abstract][Full Text] [Related]
13. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
Lubbe WJ; Zuzga DS; Zhou Z; Fu W; Pelta-Heller J; Muschel RJ; Waldman SA; Pitari GM
Cancer Res; 2009 Apr; 69(8):3529-36. PubMed ID: 19336567
[TBL] [Abstract][Full Text] [Related]
14. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
[TBL] [Abstract][Full Text] [Related]
15. APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
Blomain ES; Rappaport JA; Pattison AM; Bashir B; Caparosa E; Stem J; Snook AE; Waldman SA
Cancer Biol Ther; 2020 May; 21(5):441-451. PubMed ID: 32037952
[TBL] [Abstract][Full Text] [Related]
16. Guanylin hormone loss could trigger colon cancer.
Tanday S
Lancet Oncol; 2014 Nov; 15(12):e537. PubMed ID: 25602115
[No Abstract] [Full Text] [Related]
17. Guanylin peptides: cyclic GMP signaling mechanisms.
Forte LR; Freeman RH; Krause WJ; London RM
Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
[TBL] [Abstract][Full Text] [Related]
18. Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.
Blomain ES; Merlino DJ; Pattison AM; Snook AE; Waldman SA
Mol Pharmacol; 2016 Sep; 90(3):199-204. PubMed ID: 27251363
[TBL] [Abstract][Full Text] [Related]
19. GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
Li P; Wuthrick E; Rappaport JA; Kraft C; Lin JE; Marszalowicz G; Snook AE; Zhan T; Hyslop TM; Waldman SA
Cancer Res; 2017 Sep; 77(18):5095-5106. PubMed ID: 28916678
[TBL] [Abstract][Full Text] [Related]
20. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
